Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

252.00
Delayed Data
As of Aug 16
 +0.70 / +0.28%
Today’s Change
216.45
Today|||52-Week Range
276.80
+10.55%
Year-to-Date
Ophthotech's Fovista Combo Regimen Disappoints in Phase III
Aug 16 / Zacks.com - Paid Partner Content
Mylan (MYL) Misses on Q2 Earnings & Sales, Lowers View
Aug 09 / Zacks.com - Paid Partner Content
Bristol-Myers Opdivo Fails Kidney Cancer Trial CheckMate-214
Aug 16 / Zacks.com - Paid Partner Content
Inovio (INO) Q2 Loss Narrower Than Expected, Revenues Beat
Aug 09 / Zacks.com - Paid Partner Content
Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move Forward
Aug 14 / TheStreet.com - Paid Partner Content
Prothena (PRTA) Q2 Loss Narrows as Roche Makes $30M Payment
Aug 09 / Zacks.com - Paid Partner Content
Puma (PBYI) Q2 Loss Narrower than Expected, Nerlynx in Focus
Aug 10 / Zacks.com - Paid Partner Content
Kite Pharma (KITE) Q2 Loss Narrower than Expected, Shares Up
Aug 09 / Zacks.com - Paid Partner Content